Vancomycin-resistant Enterococcus (VRE) has become an increasingly imp
ortant nosocomial pathogen. Questionnaires were sent to all New York C
ity (NYC)-licensed laboratories to ask about testing procedures used,
number of isolates identified, species identified, and vancomycin susc
eptibility for enterococcal isolates in 1993. Of 127 laboratories, 118
(93%) responded, Fifty-three (45%) of the 118 laboratories reported b
oth the number of enterococcal isolates tested and the number of VRE i
solates identified during 1993; 15 (28%) of the 53 laboratories did no
t isolate VRE, and the remaining 38 laboratories identified 3,822 (8.1
%) VRE isolates. VRE was first identified by a NYC-licensed (commercia
l) laboratory in 1988. Among NYC hospital laboratories, 65 (97%) of 67
identified at least one VRE isolate during 1989-1993. This survey dem
onstrates that there has been a marked increase in the number of VRE i
solates identified in NYC laboratories.